tional IL-2 by reversed-phase and gel-ifitration HPLC analysis. However, even highly purified KTGF falls to stimulate the proliferation of CTLL-2 cells. The observation that epidermal epithelium produces a trophic factor for T lymphocytes may help explain the basis for preferential proliferation of T cells in the microenvironment of skin in certain dermatologic disorders. Further, it suggests that different IL-2-dependent T-cell lines may have distinct growth requirements and that nonlymphocyte cell types may produce factors capable of maintaining the growth of T cells.
In the last decade, it has become necessary to modify the perception of the epidermis as comprising an immunologically inert barrier between the environment and the organism's internal milieu. Studies of the malignant cells of cutaneous T-cell lymphoma (CTCL) by Edelson (1) led to the suggestion that the skin may actively influence T-cell maturation, and the proposal of skin-associated lymphoid tissue (SALT) by Streilein (2) provided a synthesis of accumulated observations indicating that the epidermis is comprised of immunologically active cells. Epidermal Langerhans cells present antigen to T cells in a well-characterized fashion that results in an antigen-specific positive immune response (2, 3) . In contrast, a putative I-J-bearing epidermal dendritic cell preferentially induces generation of antigen-specific suppressor T cells (4) . Recent evidence suggests that a Thy-i-bearing epidermal dendritic cell may behave in a similar fashion (5) . Therefore, skin is an organ in which immunologically competent cells mediate active processes designed to recognize and respond to foreign antigen.
The SALT model, as originally postulated, did not propose an immunologic role for epidermal epithelial cells (keratin- ocytesj. Recent studies suggest that this perception must be modified as well. Keratinocytes, the predominant cell in the epidermis, have been shown to make an interleukin 1 (IL-1)-like molecule (6, 7) . This epidermal cell-derived thymocyte-activating factor (ETAF) is produced in response to injurious environmental stimuli (8) . ETAF, like IL-1, can provide a second signal for T-cell proliferation (6) and is a potent T-cell chemoattractant (9) . Recently, keratinocytes were shown to produce a cytokine that sustained the growth of IL-3-dependent cell lines (10) . Though incompletely understood, the role played by the keratinocyte in immune responses initiated in the epidermis would appear to be important.
We report that both normal murine keratinocytes and a transformed murine keratinocyte cell line produce a factor that is capable of sustaining the growth of the IL-2-dependent cell line HT-2 in the absence of lymphocyte-derived IL-2. This keratinocyte-derived T-cell growth factor (KTGF) is functionally distinct from IL-2. KTGF will support the growth of HT-2 cells (11) but, unlike IL-2, will not support the growth of another IL-2-dependent cell line, CTLL-2 (12) . Further, KTGF is functionally and biochemically distinct from several other epidermal cytokines.
MATERIALS AND METHODS
Mice. Mice were obtained either from The Jackson Laboratory, or raised in our colony at Yale University School of Medicine, New Haven, CT.
Lymphocyte Cell Lines. D1O.G4.1 (D10), a murine helper-T-cell clone, and 3D3, a clonotype-specific monoclonal antibody that activates the T-cell receptor of D10, were provided by C. Janeway, Jr. (Yale University) and were maintained as described (13) . HT-2 and CTLL-2 (IL-2-dependent T-cell lines) cells were obtained from P. Marrack (National Jewish Hospital) and were maintained in Click's EHAA medium (Irvine Scientific) with 10% fetal bovine serum by weekly feeding with a 10% (by volume) rat T-cell growth factor (TCGF) preparation. Rat Reversed-Phase High-Performance Liquid Chromatography. RP-HPLC was performed on a gradient processor system (Bio-Rad) with a 250 x 4.6 mm Hi-Pore RP-318 C18 column (Bio-Rad). Solvent A was 0.05% trifluoroacetic acid in water, and solvent B was 0.05% trifluoroacetic acid in acetonitrile. All reagents were HPLC grade. The column was equilibrated in solvent A. Serum-free cell supernatants were concentrated, dried with a vacuum centrifuge, suspended to 0.5 ml in solvent A and filtered with a 0.45-,um fluorocarbon HPLC filter (Gelman) prior to injection onto the C18 column. A 0-100% acetonitrile gradient was applied, and samples were eluted at a flow rate of 1 ml/min. Fractions (1 ml) were collected in polypropylene tubes, dried with a vacuum centrifuge, and resuspended in either tissue culture medium or phosphate-buffered saline (for subsequent GF-HPLC analysis). All samples were sterilized by filtration before use in the assays.
Gel Filtration High-Performance Liquid Chromatography. GF-HPLC was performed using a Bio-Rad HPLC system with a Bio-Sil TSK-125 column (Bio-Rad). After RP-HPLC, biologically active fractions were diluted in phosphatebuffered saline (0.15 M NaCl/10 mM phosphate, pH 7.4) and 0.4-0.5 ml was injected onto the TSK-125 column. The material was eluted with phosphate-buffered saline at a flow rate of 1 ml/min and 0.4-ml fractions were collected. All samples were sterile-filtered prior to use in the assays.
RESULTS
Media conditioned by primary cultures of confluent murine epidermal cells were tested for their capacity to stimulate [3H]thymidine incorporation ("proliferation") by the IL-2-dependent cell lines HT-2 and CTLL-2 (13, 14) . Both cell lines proliferated in response to recombinant IL-2 (rIL-2), and neither proliferated in the absence of exogenous IL-2 (Table 1) . Conditioned media (CM) from primary mouse epidermal cell cultures, however, stimulated the growth of HT-2 cells but did not permit the growth of CTLL-2 cells (Table 1 ). The CM-or rIL-2-induced proliferation of HT-2 or CTLL-2 cells was titratable, and the values shown in Table  1 represent the maximal proliferation observed for each titration curve (i.e., 30% CM by volume or 0.17 unit of rIL-2 per ml). Luger et al. (10) reported that murine epidermal cell CM has no effect on CTLL-2 cells; however, the observation that such supernatants could stimulate the proliferation of HT-2 cells was new. While such primary cultures of epidermal cells contain >95% keratinocytes (14) , contamination by dendritic cells and melanocytes is unavoidable. Subsequent experiments were designed to determine the cellular source of this novel activity.
Pam 212 is a spontaneously transformed BALB/c keratinocyte cell line that is devoid of non-kertitinocyte cell types as determined by electron microscopic analysis (14) .
We tested CM from this homogeneous cell line on both HT-2 and CTLL-2 cells in an effort to determine whether keratinocytes were the source of the CM activity described in Table 1 . Fig. 1 shows the results of a representative experiment. IL-2-rich CM from AOFS cells had virtually identical activity on both HT-2 and CTLL-2 cell lines, suggesting no significant difference between the sensitivity of these cells to conventional IL-2. In contrast, Pam 212 CM had significant activity on HT-2 cells and no activity on CTLL-2 cells. This experiment indicated that keratinocytes were the source of this novel "T-cell growth factor" activity, which appeared to be specific for HT-2 cells. Indirectly, it confirmed previous reports by others that conventional IL-2 activity is absent from keratinocyte supernatants, as measured by induction of CTLL-2 (10) or CT6 proliferation (16) .
Three possible explanations of these findings which would not require the participation of a factor different from conventional IL-2 were entertained. First, the possibility that a factor(s) in Pam 212 CM induced HT-2 cells to recover their capacity to synthesize and release IL-2 was tested. To test this possibility, HT-2 cells were grown in Click's medium with 10% fetal bovine serum and 10% Pam 212 CM. CM from HT-2 cells fed with Pam 212 CM was tested on both CTLL-2 and HT-2 cells. CM produced in this fashion induced titratable proliferation of HT-2 cells (since it contained Pam 212 CM) but had no activity on CTLL-2 cells, indicating an absence of conventional IL-2 (data not shown).
Second, inhibitors of IL-2 have been described (17) . We tested the possibility that Pam 212 produced both IL-2 and an IL-2 inhibitor that was more active on CTLL-2 cells than on HT-2 cells, thereby preventing proliferation of CTLL-2 cells. CTLL-2 cells were cultured in serial dilutions of AOFS CM or, alternatively, in identical dilutions of AOFS CM to which Pam 212 CM at 30% or 10% by volume was added (Fig. 2 ). This activity, produced by both normal keratinocytes and a transformed murine keratinocyte line, was named keratinocyte T-cell growth factor (KTGF) and attempts to further characterize it were made. Subsequent experiments were aimed at the biochemical characterization of this factor in an attempt to distinguish it from both ETAF and T-cellderived ("conventional") IL-2. We will refer to chromatographic fractions derived from Pam 212 CM that stimulate HT-2 cells as having KTGF activity and fractions that stimulate D10 cells in the presence of monoclonal antibody 3D3 as having ETAF activity.
RP-HPLC was used to separate the IL-1-like activity ascribed to ETAF (D1O/3D3) from the KTGF activity (HT-2). Both activities were eluted in the range 45-55% acetonitrile, a region which revealed little protein as measured by absorption at 220 nm (data not shown). Peak ETAF activity was eluted reproducibly at a slightly lower percentage of acetonitrile than was KTGF, though there was some overlap of activities (Fig. 3) . These fractions had no activity on CTLL-2 cells. Fractions obtained from RP-HPLC which contained predominantly ETAF activity or predominantly KTGF activity were analyzed separately by GF-HPLC. The ETAF activity was eluted at an apparent molecular weight of 10,000-20,000 (Fig. 4) , consistent with previous reports of its molecular weight (10) . Fractions containing ETAF activity had no significant activity on HT-2 cells. In contrast, KTGF activity was eluted at Mr 25,000-35,000, and these fractions had no significant activity on D10 cells, either in the presence or absence of 3D3.
The molecular weight of KTGF is similar to that reported for murine IL-2, even though its functional activities are distinct. We therefore analyzed Con A-stimulated mouse spleen cell supernatants, which contained significant TCGF activity, by RP-HPLC and subsequently assayed these fractions on HT-2 cells. We also analyzed Pam 212 CM in an identical fashion (Fig. 5) . Murine TCGF was eluted in one major peak that had significant activity on HT-2 cells. KTGF activity also was eluted in one major peak at the same percentage acetonitrile. phosphate-buffered saline were tested for ETAF and KTGF activity as described for Fig. 3 . Samples (0.5 ml) containing either activity were injected onto a TSK-125 GF-HPLC column. A mobile phase of phosphate-buffered saline was used, and 0.4-ml fractions were collected, filtered, and tested for ETAF and KTGF activity as described. The column was calibrated with thyroglobulin (TG, Mr 667,000), IgG (Mr 158,000), ovalbumin (Ova, M, 45,000), Myoglobin (Myo, Mr 17,000), and cyanocobalamin (CNCb, Mr 1350). Mean values are plotted, and fractions with activity in either assay differed from background by at least P < 0.01.
DISCUSSION
We have described an activity derived from medium conditioned by cultured murine keratinocytes. This activity, KTGF, is unique among previously described cytokines by two-criteria. First, it is a factor produced by cultured epithelial cells that can support the growth of an IL-2-dependent cell line. With one exception (18), IL-2 appears to be made only by activated T lymphocytes or related cell lines (19) (20) (21) . Second, although KTGF is coeluted with conventional IL-2 in RP-HPLC and GF-HPLC, it is functionally distinct from IL-2 in that it stimulates one (HT-2) but not another (CTLL-2) IL-2-dependent cell line.
The relationship of KTGF to TCGF on a molecular and biochemical level is a question of importance. Both molecules were eluted from an RP-HPLC column at 45-55% acetonitrile. Thus, both molecules not only have similar Serum-free Pam 212 CM and serum-free CM from Con A-stimulated murine spleen cells were concentrated 15-fold by Amicon YM10 diafiltration, and 0.5 ml of each concentrate was injected onto an RP-318 column. A biphasic 0-100o acetonitrile gradient was applied as shown. Fractions (1 ml) were vacuum centrifuged, reconstituted in Click's medium with 5% fetal bovine serum, filtered, and assayed on HT-2 cells. Mean values are plotted, and fractions with activity in the HT-2 assay differed from background by at least P < 0.01. hydrophobic properties but also are relatively more hydrophobic than the majority ofprotein present in their respective CM. Additionally, IL-2 and KTGF cannot be adequately distinguished on the basis of their molecular weight as determined by GF-HPLC. Although rIL-2 has an apparent Mr of 17,000, EL-4-derived IL-2 activity has a more complex elution profile showing activity near Mr 30,000 (20) . KTGF activity from CM not previously subjected to RP-HPLC has an apparent Mr, on GF-HPLC, similar to that of EL-4 IL-2 (T.S.K., unpublished observations). This suggests that the two activities may be structurally related.
The important distinction between KTGF and IL-2 relates to their differential effects on two IL-2-dependent cell lines. IL-2 (as well as IL-2 derivedfrom spleen cell cultures, AOFS cells, and EL-4 cells) stimulates the growth of both HT-2 and CTLL-2 cells, whereas KTGF stimulates only HT-2 cells. In no experiment did CTLL-2 cells incubated with crude or purified KTGF incorporate more [3H]thymidine than control CTLL-2 cells. Our results indicate that (i) the difference between IL-2 and KTGF stimulation is not due to the presence of factors that inhibit CTLL-2 proliferation; (ii) KTGF does not work by inducing HT-2 synthesis ofIL-2; and (iii) HT-2 and CTLL-2 have roughly equivalent sensitivities to T-cell-derived IL-2. Therefore, the data suggest that CTLL-2 cells are unable to recognize KTGF as a stimulus for proliferation.
Both HT-2 and CTLL-2 cells are considered to be dependent on exogenous IL-2 for growth. The differential effect of KTGF on these two cell lines raises several possibilities. First, HT-2 may be a cell line that can grow in response to factors unrelated to IL-2. Second, KTGF may be a factor that is similar but not identical to IL-2 and that can be recognized as a growth factor by HT-2 but not CTLL-2 cells. This would suggest a functional heterogeneity of IL-2 receptors on a different basis than high or low affinity for conventional IL-2. Third, KTGF and IL-2 may have an identical core structure which is modified by posttranslational events. This, too, would suggest a functional heterogeneity of IL-2 receptors and would require that keratinocytes both synthesize conventional IL-2 and modify it posttranslationally in a different fashion. Fourth, IL-2 obtained from spleen cells (for instance) may contain a variety of subspecies of IL-2 that differ by various posttranslational modifications. Some of these subspecies may share with KTGF differential effects on IL-2-dependent cell lines, though the unfractionated mixture (T-cell growth factor) would be capable of stimulating both. Because HT-2 and CTLL-2 cell lines are rarely used concomitantly to test for IL-2 activity, this diversity might still be unappreciated. Since rIL-2 (which by definition is not posttranslationally modified if expressed in Escherichia coli) stimulates both cell lines, this hypothesis would suggest that posttranslational modification of IL-2 serves to limit its spectrum of activity on target cells.
Although further studies are required to test most of these possibilities, the first possibility outlined above is without precedent. HT-2 is a well-characterized Thy-1.2+, Ly-l+, Ly-2-helper-T-cell line derived from a BALB/c thymocyte population immunized with ovine erythrocytes (11) . Proliferation of HT-2 cells is widely used as a quantitative assay for IL-2. Further, the IL-2-like effect of KTGF is not unique to HT-2 cells. A given cell line may differ in its responsiveness to KTGF (and, indeed, IL-2) depending on the condition of its growth and maintenance. The cloned helper-T-cell line D10.G4.1 can, under certain circumstances, proliferate in response to KTGF. This is true of a restricted number of T-cell lines and clones; however, all Ly-l-, Ly-2+ T-cell lines tested thus far cannot use KTGF as a growth factor (unpublished results). CTLL-2 cells are Thy-1+, Ly-1-, Ly-2', derived from cytotoxic T cells from BALB/c spleen cells (12) , and unable to respond to KTGF. The intriguing possi-bility exists, therefore, that KTGF may be a trophic factor for certain helper (or Ly-1) T-cell lines to the exclusion of cytotoxic (or other Ly-2+) T-cell lines.
Central to the issues outlined above is the question of whether KTGF exerts its effect via the IL-2 receptor. If KTGF (or certain types of IL-2 that differ by posttranslational modification) binds to IL-2 receptors on some classes of target T cells but not others, this suggests a new level of immunoregulation. That is, release of IL-2 and/or its analogs and expression of different IL-2 receptors might provide the potential for a wide variety of regulatory signals to T-cell populations.
Support for the idea that the epidermis makes factors specific for some but not all T cells comes from studies involving cutaneous T-cell lymphoma (CTCL). CTCL is the most common adult lymphoma and is manifested initially as T-cell infiltration of the dermis and epidermis by neoplastic helper T cells (22, 23) . This localized disease ultimately becomes disseminated, apparently when such T cells lose their epidermotropism. ETAF, like IL-1, is chemotactic for T cells (9) and may play some role in the epidermotropic behavior of these T cells. Factors that maintain the growth of these T cells in situ have long been postulated but never described. KTGF offers a potential explanation for the epidermotrophic phase of CTCL.
Why should epidermal cells produce factor(s) capable of replacing IL-2 in the growth of certain T cells? The fact that skin separates the body from a potentially hostile environment might dictate that T-cell-mediated immune responses originating in skin, especially those which activate helper/ inducer cells, receive an augmentative signal. Perhaps more important, several studies have shown that keratinocytes share both structural and functional properties with thymic epithelial cells (24) . Keratinocytes produce a factor that reacts with an anti-thymopoetin antibody (25) , and murine bone marrow cells can be stimulated to express Thy-i and to produce terminal deoxynucleotidyltransferase (an enzyme produced by thymocytes but not mature T cells) when cultured with keratinocytes (26) . Biopsies performed on CTCL patients indicate that T cells found in epidermal infiltrates bear the Thy-1 antigen (human), a marker unique to human thymocytes (23) . It is interesting to speculate that KTGF may play a role in the ability of epidermis to replace or complement some of the activities of the thymus with regard to T-cell growth and maturation.
KTGF further amplifies the concept of SALT. That epithelial cells can produce a T-cell growth factor, an activity previously considered unique to T lymphocytes, adds another dimension to this paradigm. To This factor appears to be identical to B-cell stimulatory factor 1 (BSF-1). The relationship of KTGF to this factor is, at present, unknown.
